Arkolith/Insider Trading/SRNE/Form 4

Smith Robin L

DirectorSorrento Therapeutics, Inc. (SRNE) · full profile →Form 4 · filed Sep 3, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 3, 2021Option exercise(M)75K$3.95$296K135K
Sep 3, 2021Option exercise(M)100K$4.89$489K235K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 3, 2021Option exercise(M)75K—$00
Sep 3, 2021Option exercise(M)100K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-054841) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML